Skip to main content
OpenTrials

Clinical trial condition

Cystinosis

Explore clinical trials studying Cystinosis. Study availability and eligibility vary by location and protocol.

41 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Cystinosis trial results

Not Yet Recruiting

European Cystinosis Cohort 2

NCT07680751

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinosis, Genetic Diseases, Inborn, +4 more
Locations
  • AP-HP_ Hôpital Charles Foix Ivry-sur-Seine, Île-de-France Region, France
View Trial Details
Not Yet Recruiting

Cystinosis and Mitochondrial Metabolism

NCT07319091

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinosis, Genetic Diseases, Inborn, +9 more
Locations
  • Service de néphrologie pédiatrique, Hôpital Femme Mère Enfant, Hospices Civils de Lyon Bron, France
  • Service de Néphrologie pédiatrique, Hôpital Jeanne de Flandre Lille, France
  • Service de néphrologie et exploration fonctionnelle rénale, Hôpital Edouard Herriot, Hospices Civils de Lyon Lyon, France
  • Service de Néphrologie pédiatrique, Hôpital de la Timone Marseille, France
View Trial Details
Completed

Neuromuscular Characterisation in Late Adolescent and Adult Cystinosis Patients

NCT05545774

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinosis, Deglutition Disorders, +17 more
Locations
  • Neurology Department, Raymond-Poincaré hospital, APHP Garches, France
  • Department of Nephrology and Transplantation Centre de référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte, Necker-Enfants Malades University Hospital, APHP Paris, France
View Trial Details
Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details
Completed

Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)

NCT01197378

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinosis, Disease Attributes, +8 more
Locations
  • California Pacific Medical Center (CPMC) Research Institute San Francisco, California, United States
  • Stanford University Medical School Stanford, California, United States
  • Emory Children's Center Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details

Related conditions